Search Within

Heiko Schoder

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (29)
  2. Journal Article (24)
  3. Research Letter (1)
Groups
  1. Department of Medicine (54)
  2. Molecular Imaging and Therapy Service (54)
  3. Population Sciences Research Program (54)
  4. Radiology, Department of (54)
  5. Hematologic Malignancies, Division of (53)
  6. Center for Hematologic Malignancies (52)

More Groups

People
  1. Steven Horwitz (49)
  2. Andrew Zelenetz (43)
  3. Alison Moskowitz (41)
  4. Paul Hamlin (41)
  5. Ariela Noy (39)
  6. Maria Palomba (38)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (8)
  6. 2020 (4)

More Years

Publications
  1. Blood (22)
  2. Journal of Clinical Oncology (7)
  3. Hematological Oncology (5)
  4. Leukemia and Lymphoma (3)
  5. Annals of Oncology (2)
  6. Blood Advances (2)

More Publications

Publishers
  1. American Society of Hematology (24)
  2. American Society of Clinical Oncology (7)
  3. Wiley Blackwell (5)
  4. Nature Publishing Group (3)
  5. Taylor & Francis Group (3)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schöder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma
    Journal Article

    Shoushtari, A. N.; Ong, L. T.; Schoder, H.; Singh-Kandah, S.; Abbate, K. T.; Postow, M. A.; Callahan, M. K.; Wolchok, J.; Chapman, P. B.; Panageas, K. S.; more...
    Melanoma Research (2016)

    Fulltext@MSK | Save
  • Prospective study of 3′-deoxy-3′-(18)F-fluorothymidine PET for early interim response assessment in advanced-stage B-cell lymphoma
    Journal Article

    Schoder, H.; Zelenetz, A. D.; Hamlin, P.; Gavane, S.; Horwitz, S.; Matasar, M.; Moskowitz, A.; Noy, A.; Palomba, L.; Portlock, C.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
    Journal Article

    Casulo, C.; Schoder, H.; Feeney, J.; Lim, R.; Maragulia, J.; Zelenetz, A. D.; Horwitz, S.
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • FDG-PET in the staging and prognosis of T-cell lymphoma
    Meeting Abstract

    Casulo, C.; Maragulia, J.; Zelenetz, A. D.; Schöder, H.; Feeney, J.; Horwitz, S. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P. A.; Gerecitano, J. F.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M.; Portlock, C. S.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save